SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?


To: Rob Fritz who wrote (89252)2/6/2001 5:45:30 PM
From: Knighty Tin  Read Replies (2) | Respond to of 132070
 
Rob, I like all of your names assuming you haven't bet the ranch on them. KEA is one where I would either take a third off the table or sell a call on half the position. I like it longer term, but I think it only has a couple more points of upside this year.

Exodus is a great first third under $20. It may go to $12, but it could also go to $30 before I could unblink my eyes.

Safeguard Scientific has always been a favorite of mine and I am buying. But I am more worried this time than I have been the other five times I bought them low. The reason is that mgt. was totally fumblethumbed on CEGE. Everyone makes mistakes, but I wonder if one of this magnitude has eroded their confidence and the confidence of their financial backers. I am willing to vote no on those two questions at 5 and change.

I think Bush is good for the old line gouger drug cos. I don't think he is good for the generic firms. That is one reason I took profits on a first third of Duramed. I still like it, but I fear a Prez who is beholden to the prescription drug industry.

I simply don't follow Tosco, so I'll pass on this one.